Entry |
|
Name |
Mericitabine (USAN/INN) |
Formula |
C18H26FN3O6
|
Exact mass |
399.1806
|
Mol weight |
399.41
|
Structure |

|
Class |
Antiviral
DG01440 Arabinofuranosyl type antiviral
DG03198 Anti-HCV agent
DG02000 HCV NS5B polymerase inhibitor
|
Efficacy |
Antiviral, NS5B polymerase inhibitor |
Comment |
Treatment of hepatitis C
|
Target |
HCV NS5B polymerase [KO: K22472] |
Pathway |
|
Brite |
Drug groups [BR:br08330]
Antiviral
DG01440 Arabinofuranosyl type antiviral
D10477 Mericitabine
DG03198 Anti-HCV agent
DG02000 HCV NS5B polymerase inhibitor
D10477 Mericitabine
Antimicrobials [BR:br08307]
Antivirals
Genome replication inhibitor
HCV NS5A/NS5B inhibitor
D10477 Mericitabine (USAN/INN)
|
Other DBs |
|
LinkDB |
|
KCF data |
ATOM 28
1 C1z C 22.3300 -16.7300
2 C1y C 22.6800 -15.3300
3 O2x O 21.5600 -14.5600
4 C1y C 20.4400 -15.4000
5 C1y C 20.9300 -16.7300
6 N5x N 26.3200 -14.6300
7 C8y C 26.3200 -13.2300
8 C8x C 25.1300 -12.5300
9 C8x C 23.8700 -13.2300
10 N4y N 23.8700 -14.6300
11 C8y C 25.1300 -15.3300
12 O5x O 25.1300 -16.7300
13 N1a N 27.5100 -12.5300
14 C1b C 19.2500 -14.7000
15 O7a O 18.0600 -15.4000
16 C7a C 16.8700 -14.7000
17 C1c C 15.6800 -15.4000
18 O6a O 16.8700 -13.3000
19 C1a C 14.4900 -14.7000
20 C1a C 15.6800 -16.8000
21 O7a O 19.7400 -17.4300
22 C7a C 19.7400 -18.8300
23 C1c C 18.5500 -19.5300
24 O6a O 20.9300 -19.5300
25 C1a C 17.3600 -18.8300
26 C1a C 18.5500 -20.9300
27 X F 23.7300 -16.7300
28 C1a C 22.3300 -18.1300
BOND 29
1 1 2 1
2 2 3 1
3 3 4 1
4 4 5 1
5 1 5 1
6 6 7 2
7 7 8 1
8 8 9 2
9 9 10 1
10 10 11 1
11 6 11 1
12 2 10 1 #Up
13 11 12 2
14 7 13 1
15 4 14 1 #Up
16 14 15 1
17 15 16 1
18 16 17 1
19 16 18 2
20 17 19 1
21 17 20 1
22 5 21 1 #Down
23 21 22 1
24 22 23 1
25 22 24 2
26 23 25 1
27 23 26 1
28 1 27 1 #Down
29 1 28 1 #Up
|